Possessing rare dual expertise in the biological and computational sciences. Cambridge University biochemistry graduate with a Ph.D. in computer science, an authority in computational biology, with leading-edge research expertise in longevity, to the rare extent of experimentally-validated drug inventions and granted patents. Biotechnology founder and CEO at Biophysical Therapeutics, which owns the IF1 consumer longevity brand. He is an expert on longevity. Further biographical information is at www.IF1.skin/michael-forrest.